December 8, 2022
FDA: Class I recall of Dewei Medical Equipment’s DNA/RNA Preservation Kits
Editor's Note
The Food and Drug Administration (FDA) on December 8 identified the recall by Dewei Medical Equipment Co of its DNA/RNA Preservation Kits as Class I, the most serious.
The kits are used to collect, preserve, and transport clinical samples that will be tested for viruses, including COVID-19.
The recall was initiated because the kits were distributed to US customers without authorization, clearance, or approval by the FDA.
Distribution dates were May 2020 to January 2022.
Free Daily News
- Waste-reduction culture, elimination of anesthetic gases slash OR emissions at USC
- Clinicians urged to rethink gynecologic pain management
- Direct-hire international nurses could offer sustainable solution to US shortage
- Healthcare leaders project revenue gains from value-based care despite persistent hurdles
- CMS updates hospital price transparency guidelines
- CDC communication breakdown raises public health risk
- Study: Shorter radiation schedule matches safety of standard prostate cancer treatment
- Poll: Healthcare cybersecurity leaders overlook AI-enabled physical security gaps
- ASC improves hospital efficiency, maintains outcomes despite higher-acuity joint replacement patients
- Hospital support staff cuts raise risk of infection, delays in care
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement